Stock Events

Stock Events

BIOVAXYS TECHNOLOGY NEW 

$0.147500
0
-$0.03-14.64%Monday 20:00

Statistics

Day High
0.2
Day Low
0.1799
52W High
0.6
52W Low
0.029
Volume
74,074
Avg. Volume
49,109
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-2.84MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.73B
Novavax is a competitor because it also focuses on developing vaccines for infectious diseases, similar to BioVaxys's focus on COVID-19 and cancer vaccines.
Moderna
MRNA
Mkt Cap75.86B
Moderna is a direct competitor in the mRNA vaccine space, particularly for COVID-19, competing with BioVaxys's vaccine development efforts.
BioNTech
BNTX
Mkt Cap24.34B
BioNTech competes in the development of vaccines for infectious diseases and cancer, directly overlapping with BioVaxys's areas of focus.
Pfizer
PFE
Mkt Cap158.45B
Pfizer, in collaboration with BioNTech, competes in the COVID-19 vaccine market, directly affecting BioVaxys's vaccine initiatives.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson competes in the vaccine market with its own COVID-19 vaccine, posing competition to BioVaxys's development efforts.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca competes in the COVID-19 vaccine space, which is a key area of development for BioVaxys.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline competes in the development of vaccines, including for infectious diseases, making it a competitor to BioVaxys.
Sanofi
SNY
Mkt Cap95.65B
Sanofi competes in the vaccine market, including efforts in developing COVID-19 vaccines, making it a competitor to BioVaxys.
Inovio Pharmaceuticals
INO
Mkt Cap119.94M
Inovio Pharmaceuticals competes in the development of DNA vaccines for infectious diseases and cancer, overlapping with BioVaxys's focus areas.

About

BIOVAXYS TECHNOLOGY CORP
Show More
CEO
James Christopher Passin
Employees
3
Country
Canada

Listings

CN
CA
BIOV.CN
STU
DE
5LB0.STU
MU
DE
5LB.MU
F
DE
5LB0.F

0 Comments

Share your thoughts

FAQs

What is BIOVAXYS TECHNOLOGY NEW stock price today?▼
The current price of BVAXD is $0.15 USD — it has decreased by -14.64% in the past 24 hours. Watch BIOVAXYS TECHNOLOGY NEW stock price performance more closely on the chart.
What is BIOVAXYS TECHNOLOGY NEW stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BIOVAXYS TECHNOLOGY NEW stocks are traded under the ticker BVAXD.
Is BIOVAXYS TECHNOLOGY NEW stock price growing?▼
BVAXD stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year BIOVAXYS TECHNOLOGY NEW has showed a -22.37% decrease.
What is BIOVAXYS TECHNOLOGY NEW revenue for the last year?▼
BIOVAXYS TECHNOLOGY NEW revenue for the last year amounts to 0 USD.
What is BIOVAXYS TECHNOLOGY NEW net income for the last year?▼
BVAXD net income for the last year is -2.84M USD.
How many employees does BIOVAXYS TECHNOLOGY NEW have?▼
As of October 10, 2026, the company has 3 employees.
In which sector is BIOVAXYS TECHNOLOGY NEW located?▼
BIOVAXYS TECHNOLOGY NEW operates in the Health & Wellness sector.
When did BIOVAXYS TECHNOLOGY NEW complete a stock split?▼
The last stock split for BIOVAXYS TECHNOLOGY NEW was on September 11, 2025 with a ratio of 1:10.
Where is BIOVAXYS TECHNOLOGY NEW headquartered?▼
BIOVAXYS TECHNOLOGY NEW is headquartered in Etobicoke, Canada.